M&A Deal Summary

Diamond Pharma Services Acquires PharmaCentral

On April 21, 2020, Diamond Pharma Services acquired life science company PharmaCentral

Acquisition Highlights
  • This is Diamond Pharma Services’ 1st transaction in the Life Science sector.
  • This is Diamond Pharma Services’ 1st transaction in the United Kingdom.

M&A Deal Summary

Date 2020-04-21
Target PharmaCentral
Sector Life Science
Buyer(s) Diamond Pharma Services
Deal Type Add-on Acquisition

Target

PharmaCentral

Dublin, United Kingdom
PharmaCentral LLP is an innovative pharmacovigilance services and medical affairs business that offers a wide range of pharmacovigilance consultancy services, based on a wealth of experience in pharmacovigilance and medical affairs in both pharma and CRO environments.

Search 214,356 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Diamond Pharma Services

Harlow, United Kingdom

Category Company
Founded 2005
Sector Business Services
DESCRIPTION

Diamond Pharma Services provides Regulatory Affairs, Pharmacovigilance, and Compliance & Quality services to support pharmaceutical and biotechnology companies in obtaining and maintaining medicinal product licenses throughout all stages of a product’s life cycle. Diamond Pharma Services was formed in 2005 and is based in Harlow, United Kingdom.


DEAL STATS #
Overall 1 of 1
Sector: Life Science M&A 1 of 1
Type: Add-on Acquisition M&A Deals 1 of 1
Country: United Kingdom M&A 1 of 1
Year: 2020 M&A 1 of 1